Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationManesh R. Patel, Robert M. Califf, Kenneth W. Mahaffey et al.|New England Journal of Medicine|2011Cited by 9.4k
Genotype-Phenotype Correlation in the Long-QT SyndromePeter J. Schwartz, Raffaella Bloise, Silvia G. Priori et al.|Circulation|2001Cited by 1.8k
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationJonathan P. Piccini, Robert M. Califf, Susanna R. Stevens et al.|Circulation|2012Cited by 499
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AFSean D. Pokorney, G. Larsen Kneller, Karen S. Pieper et al.|Journal of the American Heart Association|2016Cited by 199
Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatmentLarissa Fabritz, Paulus Kirchhof, Eduard Guasch et al.|Nature Reviews Cardiology|2015Cited by 140